Results 31 to 40 of about 20,649 (250)
Future Pharmacology, 2021 Skin and soft tissue infections (SSTIs) have increased problematically in hospital and ambulatory settings due to the poor immunity of hosts and multidrug-resistant pathogens.
A. Gangwar +3 more
semanticscholar +1 more source
International Journal of Advanced Medical and Health Research, 2014 Background and Aims: Mupirocin is a topical antibiotic that has been used extensively for treating methicillin-resistant Staphylococcus aureus (MRSA) associated infections.
Charan Kaur Dardi
doaj +1 more source
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects [PDF]
, 2009 Staphylococcus aureus in the nose is a risk factor for endogenous staphylococcal infection. UK guidelines recommend the use of mupirocin for nasal decolonization in certain groups of patients colonized with methicillin-resistant S.
Bax, R, Coates, A, Coates, T
core +2 more sources
Scientific Reports, 2022 Nasal decolonization procedures against the opportunistic pathogen Staphylococcus aureus rely on topical antimicrobial drug usage, whose impact on the nasal microbiota is poorly understood. We examined this impact in healthy S.
Valérie O. Baede +5 more
semanticscholar +1 more source
Bacterial infections in neonates following mupirocin-based MRSA decolonization: A multicenter cohort study [PDF]
, 2017 OBJECTIVETo characterize the risk of infection after MRSA decolonization with intranasal mupirocin.DESIGNMulticenter, retrospective cohort study.SETTINGTertiary care neonatal intensive care units (NICUs) from 3 urban hospitals in the United States ...
Bryant, Kristina +4 more
core +3 more sources
The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost- effectiveness [PDF]
, 1991 Nasal carriage of Staphylococcus aureus is a risk factor for the development of infections caused by S. aureus in haemodialysis patients. This study compared the incidence of bacteraemia caused by S.
Baere, Y.A. de +4 more
core +1 more source
The Egyptian Journal of Medical Microbiology, 2022 Background: Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) can be eradicated by topical mupirocin application. Mupirocin resistance, on the other hand, is becoming more widespread.
S. Taha, N. Kamel, L. Metwally
semanticscholar +1 more source
Reduction in the colonization of central venous cannulae by mupirocin [PDF]
, 1991 In an in-vitro simulation of an intravascular cannula enclosed in a fibrin sheath, 0.03 mg1(-1) of mupirocin prevented significant colonization [greater than 15 colony forming units (cfu)] by two clinical isolates of Staphylococcus epidermidis and one ...
Casewell, M. W., Hill, R.L.R.
core +1 more source
Applied microbiology, 2022 This novel study investigated the loading of mupirocin nanoparticles into a hydrogel which was expected to enhance the antibacterial activity of mupirocin.
Sukanjana Kamlungmak +4 more
semanticscholar +1 more source
Mupirocin resistance in methicillin-resistant Staphylococcus aureus isolates from anterior nares of healthcare workers of a tertiary care hospital [PDF]
Journal of Krishna Institute of Medical Sciences University, 2022 Background: Nasal colonization of Staphylococcus aureus is very common among health care workers, as part of a comprehensive Methicillin Resistant Staphylococcus aureus (MRSA) decolonization strategy, Mupirocin (Pseudomonic acid) is a topical antibiotic ...
Manjushree V. Mulay +2 more
doaj